TotalMarketCap

Cartesian Therapeutics

RNACNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$205.168 M

$6.78 -0.57%

Close of 6 Nov 2026

As of 6 Nov 2026, Cartesian Therapeutics (RNAC) has a market capitalization of $205.2M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$2.80M

#3359 by revenue

Earnings

-$130.3M

Loss-making

Shares outstanding

30,503,005

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #244ADC TherapeuticsADCT$207.5M
  2. #245Sol-Gel TechnologiesSLGL$206.3M
  3. #246Cartesian TherapeuticsRNAC$205.2M
  4. #247Bright Minds BiosciencesDRUG$201.3M
  5. #248Eledon PharmaceuticalsELDN$199.9M

What if Cartesian Therapeutics were worth as much as…

Open the what-if tool →

Gold $28.2T

$933,285.25

Per share 137,628× higher

Bitcoin $1.53T

$50,498.44

Per share 7,447× higher

Apple $5.02T

$165,781.66

Per share 24,447× higher

Or at a round number

$500.0M$1.00B$2.00B$5.00B

Where these numbers come from

Share counts and financials for Cartesian Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.